Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
WuXi Biologics Provides Corporate Updates 2022-10-27 22:13
Simcere Receives FDA Clearance of Investigational New Drug Application (IND) for Bi-functional Fusion Protein, SIM0237 2022-10-27 21:25
Kintor Pharma Announces Completion of Subject Enrollment and Dosing in Phase I Clinical Trial of AR-PROTAC(GT20029) in the US 2022-10-27 21:22
Happiness Development Group Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement 2022-10-27 20:00
Cambrex to Invest $16.5 Million in New R&D Facility in Minneapolis, Minnesota and Expansion in Charles City, Iowa 2022-10-27 18:00
Tsinghua SIGS Virtual Open Day 2023 | Where your future starts 2022-10-27 16:59
Antengene to Host Research and Development Day on November 15th and 17th, 2022 2022-10-27 11:07
Telix Recognised as Company of the Year at AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards 2022 2022-10-27 10:23
Cali Biosciences Announces Publications of Phase IIa Results of Long-Acting Ropivacaine (CPL-01) 2022-10-27 10:07
Forsea Attracts USD5.2M to Expand Cultivated Seafood, Without Harming Sea Life 2022-10-27 09:00
SUCCESSFUL PASSING OF EU QP AUDIT ON TOT BIOPHARM'S COMMERCIAL PRODUCTION BASE FOR MONOCLONAL ANTIBODY DRUG SUBSTANCES AND ANTIBODY DRUG CONJUGATES 2022-10-27 08:00
JW Therapeutics and 2seventy bio Announce Strategic Partnership to Accelerate the Research and Development of T Cell-based Immunotherapies 2022-10-27 07:53
Samsung Biologics Reports Third Quarter 2022 Financial Results 2022-10-27 07:35
Telix and UniQuest to Collaborate on Radiolabelled Immune Targeting Peptide 2022-10-27 06:44
Alterity Therapeutics Announces Presentation of MRI Data from the bioMUSE Natural History Study at the American Neurological Association Annual Meeting 2022-10-26 19:25
WuXi AppTec Reports Record Year-to-Date Results in 2022, Third Quarter Revenue over RMB10 Billion 2022-10-26 19:06
Meet the female scientists who develop cellular and gene therapies 2022-10-26 17:07
First satellite bioanalytical lab offers fastest option for PBMC processing in Australian clinical trials 2022-10-26 17:00
ImmVira announced its signing of Series C+ financing and negotiation with further investors for the round 2022-10-26 14:26
Alwin Capital's New Dual-Currency Fund Closed and Exceeded Fundraising Target 2022-10-25 23:10
1 146 147 148 149 150 453